More News! 1 Nov 2017 Swiss Biotech & French Pharma Reverse Damage in Multiple Sclerosis A candidate multiple sclerosis treatment from GeNeuro and its partner Servier showed some remyelination in a post hoc analysis of Phase IIb data. GeNeuro’s stock rose by 30% on Monday following an announcement of promising results from its relapsing-remitting multiple sclerosis drug, GNbAC1. After six months, the highest dose demonstrated an anti-inflammatory effect and seemed to stimulate […] November 1, 2017 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 1 Nov 2017 Belgian Biotech Launches IPO, Readying Itself to Fight Multiple Sclerosis Apitope develops highly specific peptide therapeutics for multiple sclerosis and other autoimmune diseases, and will now launch an IPO on Brussels Euronext. Apitope hopes to treat a number of autoimmune diseases affecting many systems throughout the body. The company has developed peptides, ‘apitopes‘, that tackle the immunological basis of the disease. The company has just […] November 1, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 1 Nov 2017 Update: Dutch VC Raises €82M for a New European Medical Biotech Fund Update (1/11/2017): BioGeneration Ventures has surpassed its third round goal of raising €75M by securing €82M. The VC has received extra support from Bristol-Myers Squibb and Johnson & Johnson Innovation. Originally published 27/06/2017 BioGeneration Ventures has secured €66M from Dutch and EU investors that will go towards biotechs developing therapeutics, diagnostics and medical devices. BioGeneration Ventures is a Dutch VC that focuses its investments on […] November 1, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Oct 2017 German Pharmacist Finds a Way to Put the Brakes on Gallbladder Cancer Research has identified a protein that drives tumor growth, which opens up a new therapeutic target for gallbladder cancer. Gallbladder cancer is often detected too late to be treated effectively as it shows few symptoms. Research, published in Oncotarget, has identified a pathway that could help to improve prognosis and treatment of the disease. Sonja Kessler discovered […] October 30, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 30 Oct 2017 French Biotech Closes €19M IPO to Treat Narcolepsy and Alzheimer’s Theranexus debuts on Euronext Paris raising €19.6M that will support the development of its pipeline of CNS drugs for narcolepsy, Parkinson’s, Alzheimer’s and neuropathic pain. Theranexus, based in Lyon, starts trading on Euronext Paris today. The company starts off with a market cap of €47.5M after closing a €19.6M IPO. With the money raised, the company […] October 30, 2017 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 30 Oct 2017 Meet the Covagen Co-Founder that Closed Europe’s Biggest Acquisition in 2014 Dragan Grabulovski co-founded the biotech that became 2014’s largest acquisition in Europe. I caught up with him to hear about the journey and what happens to a founder after his or her company is acquired. Dragan Grabulovski was doing a PhD in pharmaceutical sciences at ETH Zurich in the group of Dario Neri when he […] October 30, 2017 - 9 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 28 Oct 2017 Biomaterials Take the Stage at Dutch Design Week The Dutch Design Week featured several biodesign projects that explore how the future will be shaped by the advance of biotechnology. Let’s have a look at some of them. Celebrated annually in Eindhoven, the Dutch Design Week has become a hotspot where designers share the latest trends and technologies. In the last few years, biodesign […] October 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Oct 2017 French Biotech Gets Together with L’Oréal to Clean up our Streets Carbios and L’Oréal have had enough of the plastics bags and packaging littering our streets and will form a consortium for the bio-recycling of plastic on an industrial scale. Today, you’ll struggle to walk along a street without seeing plastic bottles, bags, and wrappers dropped by the wayside… but thankfully, help is at hand. Carbios, […] October 27, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 27 Oct 2017 Lack of Permanent Academic Roles is Frightening News for PhD Students With Halloween around the corner, PhD students probably felt safe from any nasty surprises for a few more days but their careers in academia may have hit a snag. PhD students work very hard, but surely it is all worth it for the guarantee of a good job at the end of it all? A study […] October 27, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2017 The FDA Recruits British Organs-on-Chips to Speed Up Drug Development CN Bio Innovations and the FDA have entered a research collaboration to better predict drug safety in drug development by using human organs-on-chips. CN Bio Innovations, a spin-out from the University of Oxford, will be working with scientists from the FDA’s Centre for Drug Evaluation and Research with the aim of integrating organ-on-a-chip technology in the […] October 26, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2017 New and Improved CRISPR: More Precise Genome Editing Now Possible US Scientists have developed a new form of CRISPR, base editing, which can repair tiny genome segments, smaller than a single gene. Here at Labiotech, we focus on European biotech, but this was too big to miss: Researchers based at MIT and Harvard have described a new way of editing DNA and RNA — base […] October 26, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2017 Here’s a Flashy New Technique to Model Disease Although we have come very far in understanding cells and their functions, many undiscovered characteristics still keep us in the dark. Creating experiments that mimic the cell’s in vivo environments as closely as possible is one of the many challenges researchers face when working with cells in their labs. Micropatterning is a technique that addresses […] October 26, 2017 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email